People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first time. Also known as tirzepatide, the drug will become available to around ...

With the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal weighs in on who should take it, how it works, and why it's not a shortcut to ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as ...

Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with fewer side effects.

The medication, Mounjaro, is also known as tirzepatide and manufactured by Lilly. It is expected to be made available ... those using it will need to eat a balanced, reduced-calorie diet and to ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular, and massively lucrative in the last few years ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other conditions because it comes in pill form, not an injection.